bioRxivCell Biology
Antiviral Effect of Hyunggaeyungyo-tang on A549 Cells Infected with Human Coronavirus
Abstract
BackgroundHerbal medicine is widely recommended to treat viral infectious diseases. Over 123,000,000 individuals have been infected with the coronavirus since a worldwide pandemic was declared in March 2020. We conducted this research to confirm the potential of herbal medicine as a treatment for coronavirus. MethodsWe infected the A549 cell line with beta coronavirus OC43 then treated with 100 g/mL Hyunggaeyungyo-tang (HGYGT) or distilled water with a control of HGYGT. We measured the mRNA expression levels of pro-inflammatory cytokines and interferon stimulated genes (ISGs) to confirm the effectiveness of HGYGT upon coronavirus infection. ResultsWe found the effects of HYGYT decrease the expression level of pPKR, peIF2, IFI6, IFI44, IFI44L, IFI27, IRF7, OASL and ISG15 when administered to cells with coronavirus infection. The expressions of IL-1, TNF-, COX-2, NF-{kappa}B, iNOS and IKK mRNA were also significantly decreased in the HGYGT group than in the control group. ConclusionThrough the reduction of the amount of coronavirus RNA, our research indicates that HGYGT has antiviral effects. The reduction of IKK and iNOS mRNA levels indicate that HGYGT reduces coronavirus RNA expression and may inhibits the replication of coronavirus by acting on NF-kB/Rel pathways to protect oxidative injury. In addition, decreases in mRNA expression levels of pro-inflammatory cytokines indicate that the HGYGT may relieve the symptoms of coronavirus infections.
- organism: human
- assay: bulk RNA-seq
- research focus: host-pathogen & immune response
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- In vitro screening of herbal medicinal products for their supportive curing potential in the context of SARS-CoV-2
H. Tran, P. Peterburs, … E. Lamy·bioRxiv·Mar 1, 2021
- In vitro screening of anti-viral and virucidal effects against SARS-CoV-2 by Hypericum perforatum and Echinacea.
L. H. Bajrai, S. A. El-kafrawy, … E. I. Azhar·Scientific ReportsPeer-reviewed·Dec 15, 2022
- The GPR4 antagonist NE-52-QQ57 increases survival, mitigates the hyperinflammatory response and reduces viral load in SARS-CoV-2-infected K18-hACE2 transgenic mice
Xin-Jun Wu, Karen A. Oppelt, … Li V. Yang·Frontiers in PharmacologyPeer-reviewed·Jul 9, 2025
- Effect of cannabidiol on apoptosis and cellular interferon and interferon-stimulated gene responses to the SARS-CoV-2 genes ORF8, ORF10 and M protein
M. F. Fernandes, J. Z. Chan, … R. E. Duncan·bioRxiv·Jan 11, 2022
- A traditional medicine, Respiratory Detox Shot (RDS), inhibits the infection of SARS-CoV, SARS-CoV-2, and the Influenza A virus in vitro
B. Hetrick, D. Yu, … Y. Wu·bioRxiv·Dec 10, 2020
- Potent Antiviral Activities of Type I Interferons to SARS-CoV-2 Infection
E. K. Mantlo, N. Bukreyeva, … C. Huang·bioRxiv·Apr 2, 2020